NSAID-sparing effect of glucosamine hydrochloride in patients with knee osteoarthritis: an analysis of data from a French database

References

• Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-223
   PubMed Web of Science ®Google Scholar
• Palazzo C, Ravaud JF, Trinquart L, et al. Respective contribution of chronic conditions to disability in France: results from the national Disability-Health Survey. PLoS One 2012;7:e44994
   PubMed Web of Science ®Google Scholar
• Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J Med 2006;354:841-8
   PubMed Web of Science ®Google Scholar
• Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull WHO 2003;81:646-56
   PubMed Web of Science ®Google Scholar
• Dillon CF, Rasch EK, Gu Q, et al. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991–94. J Rheumatol 2006;33:2271-9
   PubMed Web of Science ®Google Scholar
• Guillemin F, Rat AC, Mazieres B, et al. Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey. Osteoarthr Cartilage 2011;19:1314-22
   PubMed Web of Science ®Google Scholar
• Haq I, Murphy E, Dacre J. Osteoarthritis. Postgrad Med J 2003;79:377-83
   PubMed Web of Science ®Google Scholar
• Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartilage 2010;18:476-99
   PubMed Web of Science ®Google Scholar
• Rostom A, Muir K, Dube C, et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol 2007;5:818-28
   PubMed Web of Science ®Google Scholar
• Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006;332:1302-8
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Ger Soc 2009;57:1331-46
   PubMed Web of Science ®Google Scholar
• Reginster JY, Neuprez A, Lecart MP, et al. Role of glucosamine in the treatment for osteoarthritis. Rheumatol Int 2012;32:2959-67
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Chevalier X, Herrero-Beaumont G, et al. Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities. BMC Res Notes 2013;6:115
   PubMedGoogle Scholar
• Glucosamine (Structoflex) prescribing information. Available at: http://www.doctissimo.fr/medicament-STRUCTOFLEX.htm. Accessed September 23, 2013
   Google Scholar
• Haute Autorité Santé (HAS) Réévaluation du Service Médical Rendu suite à la saisine de la Commission de la transparence du 16 juin 2011 par la Direction de la Sécurité Sociale en vertu de l’article R 163-19/6° du code de la sécurité sociale. Indication: ‘Soulagement des symptômes liés à une arthrose légère à modérée du genou’, 2011. Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-10/compte-rendu_ct_21_09_2011.pdf. Accessed October 1, 2013
   Google Scholar
• Structoflex® capsule formulation description. Available at: http://www.pharmaetudes.com/ressources/3-annee-pharmacie/galenique/Capsules.pdf Accessed October 2, 2013
   Google Scholar
• Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomized, placebo-controlled trial. Lancet 2001;357:251-6
   PubMed Web of Science ®Google Scholar
• Pavelká K, Gatterová J, Olejarová M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002;162:2113-23
   PubMed Web of Science ®Google Scholar
• Bruyere O, Honore A, Ethgen O, et al. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthr Cartilage 2003;11:1-5
   PubMed Web of Science ®Google Scholar
• Herrero-Beaumont G, Román Ivorra JA, Trabado MC, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms. A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 2007;56:555-67
   PubMed Web of Science ®Google Scholar
• Rozendaal RM, Koes BW, van Osch GJ, et al. Effect of glucosamine sulfate on hip osteoarthritis. Ann Intern Med 2008;148:268-77
   PubMed Web of Science ®Google Scholar
• Rozendaal RM, Uitterlinden EJ, van Osch GJ, et al. Effect of glucosamine sulfate on joint space narrowing, pain and function in patients with hip osteoarthritis: subgroup analyses of a randomized controlled trial. Osteoarthr Cartilage 2009;17:427-32
   PubMed Web of Science ®Google Scholar
• Petersen SG, Saxne T, Heinegard D, et al. Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training. Osteoarthr Cartilage 2010;18:34-40
   PubMed Web of Science ®Google Scholar
• Towheed TE, Maxwell L, Anastassiades TP, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005;(2):CD002946
   Google Scholar
• Wandel S, Jüni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010;341:c4675
   PubMed Web of Science ®Google Scholar
• Giacovelli G, Rovati LC. Glucosamine and osteoarthritis. Conclusions not supported by methods and results. BMJ 2010;341:c6338
   PubMed Web of Science ®Google Scholar
• Reginster JY, Altman RD, Hochberg MC. Glucosamine and osteoarthritis. Prescribed regimen is effective. BMJ 2010;341:c6335
   PubMedGoogle Scholar
• Pelletier JP, Hochberg MC, du Souich P, et al. Glucosamine and osteoarthritis. Effect size is encouraging. BMJ 2010;341:c6328
   PubMedGoogle Scholar
• Groves T. Report from BMJ post publication review meeting. BMJ 2011. Available at: http://www.bmj.com/content/341/bmj.c4675.long/reply#bmj_el_247719. Accessed October 1, 2013
   Google Scholar
• Bruyère O. Large review finds no clinically important effect of glucosamine or chondroitin on pain in people with osteoarthritis of the knee or hip but results are questionable and likely due to heterogeneity. Evid Based Med 2011;16:52-3
   PubMedGoogle Scholar
• Becher H, Kostev K, Schröder-Bernhardi D. Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 2009;47:617-26
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment (2013). 16th ed. Oslo 2012. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology. Available at: http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf. Accessed August 14, 2013
   Google Scholar
• Derfoul A, Miyoshi AD, Freeman DE, et al. Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthr Cartilage 2007;15:646-55
   PubMed Web of Science ®Google Scholar
• Committee for Medicinal Products for Human Use (CHMP) 2006. Opinion following an article 29(4) referral for Glucomed and associated names (glucosamine hydrochloride). London: European Medicines Agency, 2006. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Glucomed_29/WC500009592.pdf. Accessed October 2, 2013
   Google Scholar
• Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55
   PubMed Web of Science ®Google Scholar
• Park SH, Hong H, Han YM, et al. Nonsteroidal anti-inflammatory drugs (NSAID) sparing effects of glucosamine hydrochloride through N-glycosylation inhibition; strategy to rescue stomach from NSAID damage. J Physiol Pharmacol 2013;64:157-65
   PubMed Web of Science ®Google Scholar
• Selvan T, Rajiah K, Nainar MS, et al. A clinical study on glucosamine sulfate versus combination of glucosamine sulphate and NSAIDs in mild to moderate knee osteoarthritis. Sci World J 2012;2012:902676
   Google Scholar
• Gerhard T. Bias: considerations for research practice. Am J Health Syst Pharm 2008;65:2159-68
   PubMed Web of Science ®Google Scholar
• Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92
   PubMed Web of Science ®Google Scholar